Please bring this to the attention of your pharmacy team(s).
Kind regards
SENT ON BEHALF OF Gerard Greene Chief Executive
Dear Contractor
The survey for the Living Well campaign ‘Keep Antibiotics Working’ is due to close on 15th January 2024.
SUMMARY
The survey for the campaign ‘Keep Antibiotics Working’ survey can be accessed here
Living Well information and resources on the current campaign ‘Take 5 steps to Well Being’ can be accessed here.
ACTION
Contractors who provide the Living Well Service and have yet to complete the online survey for the campaign ‘Keep Antibiotics Working’ can access the survey here.
In the event that a survey is not completed, SPPG may seek to recover all, or part of, the associated funding via an adjustment to the pharmacy’s BSO payment account.
Please be aware from 1st December 2023 to 31st March 2024 a quality assurance pilot on the Living Well service is being undertaken by SPPG. Further information can be accessed from the letter issued by SPPG on 6th November 2023.
For any further information please contact CPNI offices.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
This update contains important information for community pharmacy teams.
Please note this summary covers the period 25 December 2023 – 5 January 2024.
‘Promoting Public Health: Alcohol Consumption’ Webinar
The Community Pharmacy Living Well ‘Know Your Units’ Campaign will run throughout February and March 2024. To support pharmacists delivering the ‘Know Your Units’ Campaign, NICPLD are running a ‘Promoting Public Health: Alcohol Consumption’ webinar on Thursday 25 January from 7-9pm.
ASCERT are delivering the webinar to enable pharmacists to identify and support individuals who drink in excess of the recommended guidelines. The content will highlight the health risks and social consequences of drinking alcohol. You will be able to understand the alcohol unit system and apply it to individual consumption, recognise the risks of mixing alcohol with medication and communicate brief advice effectively and confidently to patients about their alcohol consumption.
Please bring this to the attention of your pharmacy team(s).
Kind regards
SENT ON BEHALF OF Gerard Greene Chief Executive
Dear Contractor,
The Department of Health issued correspondence 4th January 2024 containing updates in relation to a national patient safety alert regarding the ongoing shortage of GLP-1 Receptor Agonists.
SUMMARY
CPNI shared previous correspondence in relation to the shortage of GLP-1 Receptor Agonists in contractor updates CPNI CU#230629A and CPNI CU#230719C.
The DoH correspondence issued 4th January 2024 supersedes the previous correspondence and provides information on the use of Rybelsus® tablets for new initiations of a GLP-1 receptor agonist (GLP-1 RA) (in line with NICE NG28), and for switching patients where necessary and appropriate.
ACTION
Ensure the information in the DoH correspondence, including the actions to be followed by healthcare professionals, is brought to the attention of your pharmacy teams.
Patients should contact their GP to discuss their options.
Kind regards,
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
Riluzole 50mg Tablets
The January Drug Tariff price of riluzole 50mg tablets (56) has been increased to £300.23.
BSO have confirmed that this price will also be applied to any prescriptions dispensed in December in Northern Ireland.
Reminder: The Department of Health (NI) has previously advised that if any patients are currently experiencing difficulties obtaining riluzole 50mg tablets from community pharmacies, they are recommended to contact the Specialist Medicines Department at the Royal Victoria Hospital on 028 9615 2200 (8.30am to 4.30pm). Patients will be aware of this process from before.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
